Evidence map›Paper›PMID 36709400›Full record

ArticleInternational journal of obesity (2005)2023

Deoxyguanosine kinase mutation F180S is associated with a lean phenotype in mice.

Cédric Francis Borreguero, Stephan Wueest, Constanze Hantel, Holger Schneider, Daniel Konrad, Felix Beuschlein, Ariadni Spyroglou

Open access · hybridFull text read
In one paragraph

Article in International journal of obesity (2005), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Cédric Francis BorregueroKlinik für Endokrinologie, Diabetologie und Klinische Ernährung, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland.
Stephan WueestDivision of Pediatric Endocrinology and Diabetology, University Children's Hospital, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-0176-8906
Constanze HantelKlinik für Endokrinologie, Diabetologie und Klinische Ernährung, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland.
Holger SchneiderMedizinische Klinik und Poliklinik IV, Ludwig-Maximilians-University (LMU), Munich, Germany.ORCID 0000-0003-1556-0951
Daniel KonradDivision of Pediatric Endocrinology and Diabetology, University Children's Hospital, University of Zurich, Zurich, Switzerland.ORCID 0000-0001-9067-4356
Felix BeuschleinKlinik für Endokrinologie, Diabetologie und Klinische Ernährung, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland. felix.beuschlein@usz.ch.ORCID 0000-0001-7826-3984
Ariadni SpyroglouKlinik für Endokrinologie, Diabetologie und Klinische Ernährung, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland.ORCID 0000-0001-9525-2275
University of Zurich · CHLMU Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDeoxyguanosine kinase (DGUOK) deficiency is one of the genetic causes of mitochondrial DNA depletion syndrome (MDDS) in humans, leading to the hepatocerebral or the isolated hepatic form of MDDS. Mouse models are helpful tools for the improvement of understanding of the pathophysiology of diseases and offer the opportunity to examine new therapeutic options.

methodsHerein, we describe the generation and metabolic characterization of a mouse line carrying a homozygous Dguok

resultsMutant animals displayed significantly lower body weights and reduced inguinal fat pad mass, in comparison to unaffected littermates. Biochemically, they were characterized by significantly lower blood glucose levels, accompanied by significantly lower insulin, total cholesterol, high density lipoprotein and triglyceride levels. They also displayed an almost 2-fold increase in transaminases. Moreover, absolute EE was comparable in mutant and control mice, but EE in mutants was uncoupled from their body weights. Histological examination of inguinal white adipose tissue (WAT) revealed adipocytes with multilocular fat droplets reminiscent of WAT browning. In addition, mRNA and protein expression of Ucp1 was increased. Mutant mice also presented differing mitochondrial DNA content in various tissues and altered metabolic activity in mitochondria, but no further phenotypical or behavioral abnormalities. Preliminary data imply normal survival of Dguok

conclusionTaken together, DGUOK mutation F180S leads to a lean phenotype, with lower glucose, insulin, and lipid levels rendering this mouse model not only useful for the study of MDDS forms but also for deciphering mechanisms resulting in a lean phenotype.

Indexed as

Adipose Tissue, WhiteTandem Mass SpectrometryAdipose Tissue, BrownAnimalsBody WeightChromatography, LiquidDNA, MitochondrialHumansInsulinMiceMutationPhenotypePhosphotransferases (Alcohol Group Acceptor)deoxyguanosine kinaseDNA, MitochondrialInsulinPhosphotransferases (Alcohol Group Acceptor)

Identifiers

PMID36709400
PMCPMC10023562
OpenAlexW4318323767

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read39
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.